跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,384 条关于
“PI3K/mTOR pathway”
全部
10,384
临床试验
5,202
药物
202
机构
23
资讯
4,957
7个月前
Sensei Biotherapeutics Acquires Faeth Therapeutics for $200M to Advance PI3K/AKT/mTOR Pathway Inhibitor PIKTOR
去年
Faeth Therapeutics Advances Novel Three-Pronged Approach for Metabolism-Driven Cancers with Promising Preclinical Results
去年
Palvella Therapeutics Receives FDA Grant for Phase 3 Trial of QTORIN Rapamycin in Microcystic Lymphatic Malformations
去年
Bimiralisib Gel Shows Promising Results in Phase 2 Trial for Actinic Keratosis
2年前
Celcuity's Gedatolisib Projected to Reach $155M Annual Revenue by 2034 for Breast Cancer Treatment
去年
Palvella Therapeutics Initiates Phase 3 Trial of QTORIN™ for Microcystic Lymphatic Malformations
3年前
Palvella Therapeutics Announces Positive Topline Results from Phase 2 Study for Microcystic Lymphatic Malformations
去年
Palvella Therapeutics Doses First Patient in Phase 3 Trial of QTORIN™ Rapamycin for Microcystic Lymphatic Malformations
上个月
Advanced Endometrial Cancer Pipeline Gains Momentum as ADCs, Immunotherapy and Targeted Combinations Reshape Treatment
去年
FDA to Discuss Paxalisib Registration Pathways for Glioblastoma with Kazia Therapeutics
第 1 页,共 496 页
上一页
下一页